Skip to main content
. 2022 Apr 11;9:861032. doi: 10.3389/fmed.2022.861032

TABLE 2.

Prognostic impacts of hourly AAT delays in the middle-aged, old, and very old groups.

Variable Patient number (%)*
Univariable analysis
Multivariable analysis
Death Survival OR (95% CI) P value Adjusted OR (95% CI) P value
The middle-aged patient (n = 968) n = 138 n = 830
Delayed AAT, hour, median (IQR) 2.0 (1.0–21.2) 2.0 (0.9–6.0) <0.001 1.002 (1.000–1.004) 0.03
Gender, male 96 (69.6) 438 (52.8) 2.05 (1.39–3.01) < 0.001 NS NS
Nursing-home residence 10 (7.2) 17 (2.0) 3.74 (1.67–8.34) 0.001 NS NS
Polymicrobial bacteremia 23 (16.7) 51 (6.1) 3.06 (1.80–5.19) < 0.001 NS NS
Pitt bacteremia score ≥4 85 (61.6) 83 (10.0) 14.43 (9.57–21.78) <0.001 12.39 (7.75–19.81) < 0.001
Source of bacteremia
Pneumonia 52 (37.7) 63 (7.6) 7.36 (4.79–11.31) <0.001 4.11 (2.37–7.12) < 0.001
Urinary tract infection 16 (11.6) 275 (33.1) 0.27 (0.15–0.46) < 0.001 0.57 (0.30–1.08) 0.09
Liver abscess 1 (0.7) 42 (5.1) 0.14 (0.02–1.00) 0.02 0.14 (0.02–1.14) 0.07
Fatal comorbidity (McCabe and Jackson classification) 80 (58.0) 205 (24.7) 4.21 (2.90–6.11) <0.001 2.26 (1.33–3.83) 0.002
Comorbidity
Hemato-oncology 80 (58.0) 228 (27.5) 3.64 (2.51–5.28) < 0.001 1.73 (1.00–3.00) 0.05
Diabetes mellitus 40 (29.0) 325 (39.2) 0.63 (0.43–0.94) 0.02 NS NS
Liver cirrhosis 36 (26.1) 134 (16.1) 1.83 (1.20–2.80) 0.004 NS NS
The old patient (n = 683) n = 104 n = 579
Delayed AAT, hour, median (IQR) 3.0 (2.0–39.3) 2.0 (1.0–6.0) <0.001 1.004 (1.002–1.006) < 0.001
Gender, male 61 (58.7) 248 (42.8) 1.89 (1.24–2.89) 0.003 NS NS
Pitt bacteremia score ≥4 65 (62.5) 79 (13.6) 10.55 (6.64–16.75) <0.001 11.08 (6.40–19.19) < 0.001
Source of bacteremia
Pneumonia 35 (33.7) 53 (9.2) 5.03 (3.07–8.26) < 0.001 1.88 (1.00–3.53) 0.05
Urinary tract infection 16 (15.4) 224 (38.7) 0.29 (0.17–0.50) <0.001 0.50 (0.26–0.97) 0.04
Fatal comorbidity (McCabe and Jackson classification) 56 (53.8) 139 (24.0) 3.69 (2.40–5.68) <0.001 4.90 (2.88–8.33) < 0.001
Comorbid hemato-oncology 55 (52.9) 184 (31.8) 2.41 (1.58–3.68) < 0.001 NS NS
The very old patient (n = 1265) n = 207 n = 1058
Delayed AAT, hour, median (IQR) 3.0 (1.2–40.0) 2.0 (1.1–8.0) <0.001 1.007 (1.004–1.011) < 0.001
Nursing-home Residence 35 (16.9) 80 (7.6) 2.49 (1.62–3.82) <0.001 1.81 (1.04–3.15) 0.03
Polymicrobial bacteremia 41 (19.8) 110 (10.4) 2.13 (1.43–3.16) <0.001 1.71 (1.03–2.82) 0.04
Pitt bacteremia score ≥4 140 (67.6) 157 (14.8) 1.88 (1.37–2.56) <0.001 9.27 (6.32–15.60) < 0.001
Inadequate source control during antibiotic therapy 18 (8.7) 21 (2.0) 4.70 (2.50–8.99) <0.001 4.70 (2.10–10.54) < 0.001
Source of bacteremia
Pneumonia 86 (41.5) 158 (14.9) 0.05 (2.93–5.60) < 0.001
Urinary tract infection 18 (8.7) 413 (39.0) 0.15 (0.09–0.25) <0.001 0.19 (0.11–0.33) < 0.001
Biliary tract infection 8 (3.9) 132 (12.5) 0.28 (0.14–0.59) <0.001 0.21 (0.09–0.50) < 0.001
Fatal comorbidity (McCabe and Jackson classification) 78 (29.5) 129 (12.9) 2.84 (2.05–3.91) <0.001 2.66 (1.77–4.01) < 0.001
Comorbidity
Hypertension 121 (58.5) 695 (65.7) 0.74 (0.54–1.00) 0.047 NS NS
Hemato-oncology 81 (39.1) 270 (25.5) 1.88 (1.37–2.56) <0.001 NS NS
Liver cirrhosis 31 (15.0) 69 (6.5) 2.53 (1.61–3.97) <0.001 2.60 (1.46–4.64) 0.001
Urological disease 16 (7.7) 137 (12.9) 0.56 (0.33–0.97) 0.04 NS NS

AAT, appropriate antimicrobial therapy; CI, confidence interval; IQR, interquartile range; OR, odds ratio; NS, not significant (by backward multivariable regression). Boldface indicates statistical significance (P < 0.05) in the logistic regression model. *Data are expressed as numbers (%), unless indicated specifically.